News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 473
- Sources here
- 17
- Companies here
- 12
Search results
Stored financial headlines
Active search
473 matching headlines
Ticker or company: INITMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Dimensional Fund Advisors LP Trims Stock Holdings in Rentokil Initial PLC $RTO
Dimensional Fund Advisors LP significantly reduced its stake in Rentokil Initial PLC by 45.9% in Q1 2026, selling over 138,000 shares but still retaining holdings valued at $5.1 million. Despite this reduction, other institutional investors increased their positions in Rentokil Initial. The company's stock …
RTO
main company
Sharemaestro market context
Price below Trend Line
52 weeks -1.1%
Definitive Healthcare Q2 2026 slides: profit beats amid revenue decline
Definitive Healthcare (NASDAQ:DH) exceeded profitability guidance in Q2 2026 despite a 9% year-over-year revenue decline, driven by strong cost management. The company reported adjusted operating income and adjusted EBITDA above expectations, leading to a 3.08% rise in shares after hours. Definitive Healthcare also raised …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Definitive Healthcare targets $220M-$222M 2026 revenue while planning Turbo general availability before year-end
Earnings Call Insights: Definitive Healthcare (DH) Q2 2026 MANAGEMENT VIEW * "Total revenue was $55.2 million, down 9% year-over-year. Adjusted EBITDA was $14.6 million, representing a margin of 26%" (CEO Kevin Coop). * "Our diversified and provider businesses continue to be further along in …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Definitive Healthcare Corp. Q2 2026: Revenue $55.2M, EPS $(0.05) — 10-Q Summary
Definitive Healthcare Corp. reported Q2 2026 results, showing revenue of $55.2M, a 9% year-over-year decline, and a narrowed net loss of $(5.4)M, with EPS at $(0.05). The company experienced customer churn, particularly among smaller accounts, and initiated a restructuring plan to cut costs. They …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Definitive Healthcare (DH) books $197M goodwill hit and faces Nasdaq bid-price risk
Definitive Healthcare (DH) reported a significant net loss of $199.8 million for the six months ended June 30, 2026, primarily due to a non-cash $197.2 million goodwill impairment charge following sustained stock price declines. The company also received a Nasdaq notice for failing to …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Form 8K Definitive Healthcare Corp For: 10 August By Investing.com
This article announces that Definitive Healthcare Corp has filed a Form 8K on August 10. The filing is provided by Investing.com, a financial markets news source. The content primarily consists of the announcement itself and includes stock market data and other news headlines from …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Infinity Natural Resources Q2 2026 Earnings: Production Growth More Than Doubles Revenue
Infinity Natural Resources reported robust Q2 2026 earnings, with revenue soaring 130% to $171.0 million and daily production increasing 75%. Despite this strong operational growth and a 131% surge in adjusted EBITDAX, diluted EPS declined by 25% due to significant share dilution. The company …
INR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +2.4%
Infinity Natural Resources Q2 Results: Net Income $108M, Production Up 75% YoY
Infinity Natural Resources reported strong Q2 2026 results, with EPS of $0.88 and revenues of $171.0 million, both exceeding analyst estimates. This performance was primarily driven by a 75% year-over-year increase in net daily production to 348.5 MMcfe/d. The company also reported a total …
INR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +2.4%
Infinity Natural Resources (NYSE: INR) grows revenue, completes Antero deal and adds new debt
Infinity Natural Resources (NYSE: INR) reported significantly increased revenue and profitability for the first half of 2026, largely due to the Antero Acquisition and higher commodity prices. The company's total assets grew to $2,187.1 million, with six-month revenues reaching $325.9 million and net income …
INR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +2.4%
Infinity Natural Resources Reports 75% Growth in Daily Production
Infinity Natural Resources announced strong second-quarter 2026 financial and operating results, reporting a 75% increase in net daily production to 348.5 MMcfe/d compared to the previous year. The company delivered a net income of $108.0 million and achieved 131% growth in Adjusted EBITDAX, reaffirming …
INR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +2.4%
Definitive Healthcare (Nasdaq: DH) Q2 2026 revenue hits $55.2M amid large write-down
Definitive Healthcare (Nasdaq: DH) reported Q2 2026 revenue of $55.2 million, a decrease from Q2 2025, and a GAAP net loss of $7.5 million. The company incurred a significant goodwill impairment charge of $197.2 million for the first half of 2026, leading to a …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
Definitive Healthcare Reports Financial Results for Second Quarter 2026
Definitive Healthcare (Nasdaq: DH) reported its second-quarter 2026 financial results, with revenue of $55.2 million, a 9% decrease year-over-year, but profits surpassing expectations. The company highlighted improvements in net dollar retention and the launch of its AI-powered healthcare intelligence platform, Turbo. Definitive Healthcare also …
DH
main company
Sharemaestro market context
Price below Trend Line
52 weeks -84.3%
bioAffinity Technologies to Add Mexican Patent to its CyPath Lung Technology IP
bioAffinity Technologies Inc. has received notification of patent allowance in Mexico for its CyPath Lung technology, further strengthening its global intellectual property portfolio. This patent protects the use of flow cytometry and specific labeling methods for detecting lung cancer cells in sputum, expanding on …
BIAF
main company
Sharemaestro market context
Price below Trend Line
52 weeks -94.7% · Next-week setup negative 39.8%